{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:45:41Z","timestamp":1789371941943,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.taap.2007.05.006","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:26:40Z","timestamp":1180096000000},"page":"46-55","source":"Crossref","is-referenced-by-count":44,"title":["Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms"],"prefix":"10.1016","volume":"223","author":[{"given":"Antonella","family":"Testa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Giachelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Appolloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Padua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Tranfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Spagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Tirindelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2007.05.006_bib1","first-page":"7130","article-title":"Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer","volume":"61","author":"Ambrosone","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00008571-200011000-00006","article-title":"Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia","volume":"10","author":"Anderer","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.taap.2007.05.006_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/mutage\/9.4.315","article-title":"Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs","volume":"9","author":"Anwar","year":"1994","journal-title":"Mutagenesis"},{"key":"10.1016\/j.taap.2007.05.006_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0165-1218(85)90121-1","article-title":"Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs","volume":"157","author":"Barale","year":"1985","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1383-5742(02)00003-0","article-title":"Biomarkers in molecular epidemiology studies for health risk prediction","volume":"511","author":"Bonassi","year":"2002","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-4608(94)00131-T","article-title":"Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study","volume":"79","author":"Bonassi","year":"1995","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.taap.2007.05.006_bib7","first-page":"1619","article-title":"Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health","volume":"60","author":"Bonassi","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/em.20115","article-title":"Human population studies with cytogenetic biomarkers: review of the literature and future prospectives","volume":"45","author":"Bonassi","year":"2005","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.taap.2007.05.006_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1191\/0960327102ht230oa","article-title":"Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations","volume":"21","author":"Burgaz","year":"2002","journal-title":"Human Exp. Toxicol."},{"key":"10.1016\/j.taap.2007.05.006_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0165-1218(88)90036-5","article-title":"International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques","volume":"204","author":"Carrano","year":"1988","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mrgentox.2005.07.008","article-title":"Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees","volume":"587","author":"Cavallo","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc1547","article-title":"Bleomycins: towards better therapeutics","volume":"5","author":"Chen","year":"2005","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.taap.2007.05.006_bib13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00008571-200111000-00004","article-title":"Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression","volume":"11","author":"Coles","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.taap.2007.05.006_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1200\/JCO.2001.19.5.1279","article-title":"Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia","volume":"19","author":"Davies","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2007.05.006_bib16","first-page":"6215","article-title":"Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione","volume":"54","author":"Dirven","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/tx950143c","article-title":"Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases","volume":"9","author":"Dirven","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2007.05.006_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1383-5718(98)00084-9","article-title":"Cytogenetic consequences after occupational exposure to antineoplastic drugs","volume":"416","author":"Fucic","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib18","first-page":"1239","article-title":"Metabolic gene polymorphism frequencies in control populations","volume":"10","author":"Garte","year":"2001","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"key":"10.1016\/j.taap.2007.05.006_bib19","series-title":"Commissione Oncologica Nazionale. Linee Guida per la sicurezza e la salute dei lavoratori esposti a chemioterapici antiblastici in ambiente sanitario","article-title":"Ministero della Sanit\u00e0, Dipartimento della Prevenzione","author":"Gazzetta Ufficiale, 236","year":"1999"},{"key":"10.1016\/j.taap.2007.05.006_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ijc.2910500302","article-title":"Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs","volume":"50","author":"Goloni-Bertollo","year":"1992","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2007.05.006_bib22","first-page":"2919","article-title":"Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage","volume":"54","author":"Hagmar","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib21","first-page":"4117","article-title":"Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH)","volume":"58","author":"Hagmar","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib23","first-page":"207","article-title":"Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer","volume":"157","author":"Hagmar","year":"2004","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.taap.2007.05.006_bib24","first-page":"5251","article-title":"Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia","volume":"54","author":"Hall","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/carcin\/18.4.641","article-title":"Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer","volume":"18","author":"Harries","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2007.05.006_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.taap.2007.05.006_bib27","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/carcin\/14.7.1479","article-title":"The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung","volume":"14","author":"Hirvonen","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2007.05.006_bib28","first-page":"1","article-title":"International Agency for Research on Cancer Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42","volume":"7","author":"International Agency for Research on Cancer","year":"1987","journal-title":"Eval. Carcinog. Risks. Hum. Suppl."},{"key":"10.1016\/j.taap.2007.05.006_bib29","first-page":"47","article-title":"Monographs on the evaluation of carcinogenic risks to humans. Pharmaceutical Drugs, IARC","volume":"50","author":"International Agency for Research on Cancer","year":"1990","journal-title":"Monogr. Eval. Carcinog. Risks Hum."},{"issue":"Suppl. 3","key":"10.1016\/j.taap.2007.05.006_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/3431712","article-title":"Measurement of chromosomal aberrations, sister chromatid exchange, hprt mutations, and DNA adducts in peripheral lymphocytes of human populations at increased risk for cancer","volume":"101","author":"Jacobson-Kram","year":"1993","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2007.05.006_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/152873901300018011","article-title":"Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs","volume":"62","author":"Jakab","year":"2001","journal-title":"J. Toxicol. Environ. Health, A"},{"key":"10.1016\/j.taap.2007.05.006_bib32","first-page":"511","article-title":"Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases","volume":"6","author":"Kelsey","year":"1997","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"key":"10.1016\/j.taap.2007.05.006_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/em.2850150205","article-title":"Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses","volume":"15","author":"Krepinsky","year":"1990","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.taap.2007.05.006_bib34","first-page":"1481","article-title":"Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area","volume":"59","author":"Liou","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-1218(94)90007-8","article-title":"Biomonitoring of nurses handling antineoplastic drugs","volume":"322","author":"Machado-Santelli","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajim.4700190609","article-title":"Chromosomal abnormalities among nurses occupationally exposed to antineoplastic drugs","volume":"19","author":"Milkovic-Kraus","year":"1991","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.taap.2007.05.006_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5271\/sjweh.2355","article-title":"Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Scand","volume":"10","author":"Nikula","year":"1984","journal-title":"J. Work Environ. Health"},{"key":"10.1016\/j.taap.2007.05.006_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1078\/1438-4639-00069","article-title":"Genetic polymorphisms and chromosome damage","volume":"204","author":"Norppa","year":"2001","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/j.taap.2007.05.006_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5271\/sjweh.2605","article-title":"Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs","volume":"6","author":"Norppa","year":"1980","journal-title":"Scand. J. Work, Environ. & Health"},{"key":"10.1016\/j.taap.2007.05.006_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mrfmmm.2006.05.030","article-title":"Chromosomal aberrations and SCEs as biomarkers of cancer risk","volume":"600","author":"Norppa","year":"2006","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-1218(90)90045-4","article-title":"Chromosome and SCE analysis in peripheral lymphocytes of persons occupationally exposed to cytostatic drugs handled with and without use of safety covers","volume":"242","author":"Oestreicher","year":"1990","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s004200000164","article-title":"Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs","volume":"73","author":"Pilger","year":"2000","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.taap.2007.05.006_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-7992(86)90154-5","article-title":"Chromosomal aberrations, SCE and urine mutagenicity in workers occupationally exposed to cytostatic drugs","volume":"174","author":"Pohlova","year":"1986","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-1110(91)90022-N","article-title":"Genotoxicity of bleomycin","volume":"257","author":"Povirk","year":"1991","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1289\/ehp.6925","article-title":"Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer","volume":"113","author":"Rossner","year":"2005","journal-title":"Environ. Health Perspect."},{"issue":"Pt. 2","key":"10.1016\/j.taap.2007.05.006_bib46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3250481","article-title":"Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera","volume":"325","author":"Rowe","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2007.05.006_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1383-5718(97)00201-5","article-title":"Cytogenetic analysis of peripheral lymphocytes in medical personnel by means of FISH","volume":"412","author":"Rubes","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0027-5107(94)90092-2","article-title":"Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents","volume":"309","author":"Sessink","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2307\/3434919","article-title":"Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations","volume":"109","author":"Smerhovsky","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2007.05.006_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1383-5718(01)00328-X","article-title":"Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations","volume":"514","author":"Smerhovsky","year":"2002","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2007.05.006_bib51","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.V95.4.1222.004k20_1222_1228","article-title":"Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study","volume":"95","author":"Stanulla","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.taap.2007.05.006_bib52","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/94.12.936","article-title":"Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer","volume":"94","author":"Stoehlmacher","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.taap.2007.05.006_bib53","first-page":"5621","article-title":"Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism","volume":"60","author":"Sweeney","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2007.05.006_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1570-0232(03)00100-4","article-title":"Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods","volume":"789","author":"Turci","year":"2003","journal-title":"J. Chromatogr., B Analyt Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.taap.2007.05.006_bib55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj2690609","article-title":"Quantification of human hepatic glutathione S-transferases","volume":"269","author":"van Ommen","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2007.05.006_bib56","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1038\/sj.onc.1207897","article-title":"Individual susceptibility to carcinogens","volume":"23","author":"Vineis","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2007.05.006_bib57","first-page":"607","article-title":"Chromosome analyses of nurses handling cytostatic agents","volume":"65","author":"Waksvik","year":"1981","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.taap.2007.05.006_bib58","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/carcin\/14.9.1821","article-title":"Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer","volume":"14","author":"Zhon g","year":"1993","journal-title":"Carcinogenesis"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X07002281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X07002281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T10:54:58Z","timestamp":1587552898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X07002281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0041008X07002281"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2007.05.006","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}